INVEST NEW DRUG 润色咨询

INVESTIGATIONAL NEW DRUGS

出版年份:1983 年文章数:249 投稿命中率:50.0%

出版周期:Bimonthly 自引率:1.6% 审稿周期:平均2月

前往期刊查询

投稿信息

投稿信息
审稿速度
平均2月 (网友贡献,非官方数据)
投稿命中率
50.0% (网友贡献,非官方数据)
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2022年中国人文章占该期刊总数量43.53% (2019年为18.98%)
自引率
1.6 %
年文章数
249
期刊官网
点击查看 (点击次数:9330)
作者需知
暂无数据
期刊简介
稿件收录要求
The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. Investigational New Drugs provides a forum for the rapid dissemination of information on new anticancer agents. The papers published are of interest to the medical chemist toxicologist pharmacist pharmacologist biostatistician and clinical oncologist. Investigational New Drugs provides the fastest possible publication of new discoveries and results for the whole community of scientists developing anticancer agents. Each issue contains original articles dealing with anticancer drug development. Other sections are devoted to invited review articles and letters to the editor. The journal also affords the opportunity to publish the proceedings of special workshops and symposia devoted to the development of new anticancer agents. Provided they add to the understanding of the investigational agents the journal is not adverse to publishing clinical trials with negative results. Investigational New Drugs cuts across all the usual lines or subdisciplines providing a locus for the presentation of relevant investigations and the discussion of critical questions appropriate to the entire field of new anticancer drug development.